کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3343418 | 1214418 | 2009 | 7 صفحه PDF | دانلود رایگان |

Strong evidence indicates that many or most adults in the United States and Europe would benefit from vitamin D supplements with respect to fracture and fall prevention, and possibly other public health targets, such as cardiovascular health, diabetes and cancer.This review discusses the amount of vitamin D supplementation needed and a desirable 25-hydroxyvitamin D level to be achieved for optimal musculoskeletal health.Vitamin D modulates fracture risk in two ways: by decreasing falls and increasing bone density. Two most recent meta-analyses of double-blind randomised controlled trials came to the conclusion that vitamin D reduces the risk of falls by 19%, the risk of hip fracture by 18% and the risk of any non-vertebral fracture by 20%; however, this benefit was dose dependent. Fall prevention was only observed in a trial of at least 700 IU vitamin D per day, and fracture prevention required a received dose (treatment dose*adherence) of more than 400 IU vitamin D per day. Anti-fall efficacy started with achieved 25-hydroxyvitamin D levels of at least 60 nmol l−1 (24 ng ml−1) and anti-fracture efficacy started with achieved 25-hydroxyvitamin D levels of at least 75 nmol l−1 (30 ng ml−1) and both endpoints improved further with higher achieved 25-hydroxyvitamin D levels.Founded on these evidence-based data derived from the general older population, vitamin D supplementation should be at least 700–1000 IU per day and taken with good adherence to cover the needs for both fall and fracture prevention. Ideally, the target range for 25-hydroxyvitamin D should be at least 75 nmol l−1, which may need more than 700–1000 IU vitamin D in individuals with severe vitamin D deficiency or those overweight.
Journal: Best Practice & Research Clinical Rheumatology - Volume 23, Issue 6, December 2009, Pages 789–795